Your browser doesn't support javascript.
loading
High mobility group box 1 antagonist limits metastatic seeding in the lungs via reduction of cell-cell adhesion.
Karsch-Bluman, Adi; Amoyav, Benzion; Friedman, Nethanel; Shoval, Hila; Schwob, Ouri; Ella, Ezra; Wald, Ori; Benny, Ofra.
Afiliación
  • Karsch-Bluman A; The Institute for Drug Research, The School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Amoyav B; The Institute for Drug Research, The School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Friedman N; The Institute for Drug Research, The School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Shoval H; The Institute for Drug Research, The School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Schwob O; The Institute for Drug Research, The School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Ella E; The Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Wald O; The Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Benny O; Division of General Thoracic Surgery, Michael E. DeBakey Department of General Surgery, Baylor College of Medicine, Houston, TX, USA.
Oncotarget ; 8(20): 32706-32721, 2017 May 16.
Article en En | MEDLINE | ID: mdl-28415753

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carbenoxolona / Proteína HMGB1 / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carbenoxolona / Proteína HMGB1 / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos